Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 25Peritoneal Neoplasms 17Fallopian Tube Neoplasms 11Colorectal Neoplasms 8Stomach Neoplasms 6Carcinoma, Ovarian Epithelial 6Neoplasms 3Hyperthermia 3Gastrointestinal Neoplasms 3Colonic Neoplasms 3Appendiceal Neoplasms 3Adrenocortical Carcinoma 3Sarcoma 2Rhabdomyosarcoma 2Recurrence 2Mesothelioma, Malignant 2Mesothelioma 2Glioma 2Glioblastoma 2Desmoplastic Small Round Cell Tumor 2Carcinoma 2Brain Neoplasms 2Adenoma, Islet Cell 2Wilms Tumor 1Retroperitoneal Neoplasms 1Rectal Neoplasms 1Pseudomyxoma Peritonei 1Postoperative Complications 1Pleural Effusion, Malignant 1Peritoneal Cavity Cancer 1

Interventions

Oxaliplatin 1Leucovorin 1Fluorouracil 1Cytoreduction Surgical Procedures 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Peritoneal Cavity Cancer × Cytoreduction Surgical Procedures × Clear all
NCT00625092 2017-11-29

Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies

Masonic Cancer Center, University of Minnesota

Phase 1 Completed
17 enrolled

Peritoneal Cavity Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡